{"id":"W4405374998","doi":"10.1016/j.iotech.2024.100749","title":"120MO Inupadenant combined with chemotherapy in patients with non-squamous NSCLC progressing on or after immune checkpoint inhibitor therapy: Results from dose-finding part of the A2A-005 trial","year":2024,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"William Osler Health System; Brampton Civic Hospital","funders":"","keywords":"Medicine; Oncology; Chemotherapy; Internal medicine; Immune checkpoint; Immune system; Immunotherapy; Immunology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005615745,0.0005039791,0.001045341,0.0006208147,0.0001241115,0.00004506138,0.0004399226,0.0007923261,0.0001025197],"category_scores_gemma":[0.00009746202,0.0002588455,0.0001971115,0.001458822,0.001130561,0.00012976,0.0001108244,0.0009977422,0.000006869141],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006580031,"about_ca_system_score_gemma":0.0008707513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001884403,"about_ca_topic_score_gemma":0.0001970915,"domain_scores_codex":[0.9968365,0.0001569704,0.001182762,0.0007612402,0.0004284193,0.0006341292],"domain_scores_gemma":[0.9979235,0.0003183671,0.0005233542,0.001075743,0.0001121243,0.00004694546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8010892,0.002104304,0.009345733,0.00005116398,0.000793136,0.0002048955,0.001579905,0.000001216713,0.02924704,0.00001316595,0.0001427378,0.1554275],"study_design_scores_gemma":[0.517886,0.0735526,0.1662041,0.006022595,0.0002726664,0.00009871741,0.001119951,0.00004715142,0.2101209,0.000132131,0.02364522,0.0008979644],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850742,0.002128243,0.000005973027,0.007875944,0.001114964,0.003312292,0.00004588827,0.0002164441,0.0002260454],"genre_scores_gemma":[0.9978413,0.000255038,0.0003863491,0.0004567822,0.0001541559,0.0005922383,0.00004667071,0.0001026409,0.0001648122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2832031,"threshold_uncertainty_score":0.9999864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01290091525342313,"score_gpt":0.2756339601567856,"score_spread":0.2627330449033625,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}